An open-label pilot study of pentostatin, mitoxantrone, and rituximab in patients with previously untreated, Stage III or IV, low-grade non-Hodgkin lymphoma
Nicholas Di Bella, Craig Reynolds, David Faragher, Joseph Muscato, Kristi A. Boehm, Lina AsmarVolume:
103
Year:
2005
Language:
english
Pages:
7
DOI:
10.1002/cncr.20820
File:
PDF, 89 KB
english, 2005